Welcome to Sheatech, Inc.
BEVS Protein Expression and Applications
About Us
Who Are We?
Sheatech, Inc., is a newly founded biotechnology company located in San Diego, CA. Focusing on innovative research in life sciences, Sheatech has two main missions: 1) develop novel technologies under the Baculovirus Expression System (BEVS) to improve the efficiency of protein expression in BEVS, 2) to provide excellent and outstanding services for protein expression in BEVS & protein purification. We are highly experienced in producing large volume protein expression with serum free medium in BEVS and have successfully contracted and worked with laboratories ranging from government and university to pharmaceutical & biotechnology companies.
In addition, we pay attention on contemporary biotechnology and recent developments, which also have impact on R&D of BEVS. Beyond recombinant protein expression for 30 years, there are a lot of publications which have applied to, including bio-insecticides, vaccines development, gene delivery of tissue engineering & cancer treatment etc. Because of BEVS applications, we can predict broad pictures of BEVS in biotechnology and medical fields in the near future. Let's cooperate together and grow together for making great progresses on your research and benefits for human beings and the earth.
Baculovirus Expression System
BEVS is one of the most versatile and powerful tools for producing mass quantities of recombinant proteins. We welcome both short term and long term projects and provide outstanding products depending on our customer's needs and requirements. Our quotes are reasonable and competitive. An example is listed under our customer service section as a reference. Our top priority is customer satisfactions!
Please feel free to contact us for additional information and a more detailed quote. We are willing to take a look at and undertake any challenges and/or projects, which may have been unsuccessfully handled by other companies. We really appreciate your business and look forward to making improvements on your new and current projects.
Recently, Sheatech research group has developed a highly quality version of baculovirus DNA, SuperBAC DNA. The SuperBAC DNA, is derived from a wild type AcMNPV genome, contains an ORF 1629 partial deletion which prevents non-recombinant virus from replicating in insect cells. In addition, SuperBAC DNA provides a positive selection for creating baculoviruses recombinants in preparation for generating recombinant protein expression in insect cells. The kit improves on the traditional method for generating recombinant baculoviruses by eliminating the tedious, time-consuming steps of plaque purification. The SuperBAC BV DNA kit will contain the SuperBAC DNA, Insect Transfection Reagent, and a positive control plasmid to monitor co-transfection efficiency. For additional information on our recent developments on Baculovirus DNA, please click to do the research for BEVS out line and recent projects etc.
